ORIENTBIO Inc. (002630) — Capital Reinvestment Ratio
ORIENTBIO Inc. (002630) has a Capital Reinvestment Ratio of 0.26x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩1.77 Billion) in capital expenditures (₩452.25 Million). Check 002630 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
ORIENTBIO Inc. Capital Reinvestment Ratio (2007–2025)
This chart tracks ORIENTBIO Inc.'s Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of ORIENTBIO Inc..
Annual Capital Reinvestment Ratio for ORIENTBIO Inc. (2007–2025)
Year-by-year Capital Reinvestment Ratio for ORIENTBIO Inc. from 2007 to 2025. See how much free cash does ORIENTBIO Inc. generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 6.37x | ₩752.29 Million | ₩4.79 Billion | ▲ +2484.5% |
| 2024 | 0.25x | ₩3.76 Billion | ₩925.25 Million | ▼ -41.2% |
| 2023 | 0.42x | ₩1.16 Billion | ₩485.64 Million | ▼ -55.5% |
| 2022 | 0.94x | ₩2.35 Billion | ₩2.21 Billion | ▲ +3107.8% |
| 2021 | 0.03x | ₩8.74 Billion | ₩256.16 Million | ▼ -99.8% |
| 2016 | 15.85x | ₩912.43 Million | ₩14.46 Billion | ▲ +397.2% |
| 2015 | 3.19x | ₩1.60 Billion | ₩5.11 Billion | ▼ -33.7% |
| 2014 | 4.81x | ₩2.17 Billion | ₩10.43 Billion | ▲ +29.3% |
| 2013 | 3.72x | ₩5.09 Billion | ₩18.94 Billion | ▲ +289.9% |
| 2011 | 0.95x | ₩3.11 Billion | ₩2.97 Billion | ▲ +460.7% |
| 2010 | 0.17x | ₩9.35 Billion | ₩1.59 Billion | ▼ -97.9% |
| 2007 | 8.11x | ₩1.52 Billion | ₩12.30 Billion | — |